Amrutanjan Health Care Limited (NSE:AMRUTANJAN)
India · Delayed Price · Currency is INR | Market Cap | 18.16B -5.7% |
| Revenue (ttm) | 4.88B +10.1% |
| Net Income | 569.03M +15.4% |
| EPS | 19.68 +15.5% |
| Shares Out | n/a |
| PE Ratio | 31.91 |
| Forward PE | n/a |
| Dividend | 4.60 (0.74%) |
| Ex-Dividend Date | Feb 6, 2026 |
| Volume | 3,315 |
| Average Volume | 12,183 |
| Open | 629.55 |
| Previous Close | 629.55 |
| Day's Range | 611.85 - 631.55 |
| 52-Week Range | 544.10 - 790.95 |
| Beta | 0.20 |
| RSI | 52.16 |
| Earnings Date | Feb 3, 2026 |
About Amrutanjan Health Care
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn corn caps; hand sanitizer under the NOGerms brand name; and fruit and rehydration juice drinks under the Fruitnik brand name. The company also offers con... [Read more]
Financial Performance
In fiscal year 2025, Amrutanjan Health Care's revenue was 4.52 billion, an increase of 7.26% compared to the previous year's 4.21 billion. Earnings were 508.35 million, an increase of 13.03%.
Financial StatementsNews
Amrutanjan Healthcare Re-launches Its Iconic Yellow Balm in Classic Glass Packaging
Amrutanjan Healthcare Limited has re-launched its iconic Yellow Balm — a household name for over 130 years — in its...